NO | Produkt | Cas nr | Ansökan | Nyckelkvalitetsindikator | ||||
Renhet | Isomer | Specifik orenhet | *Max1 | Fukt | ||||
1 | FMOC-CYS (ACM) -OH | 86060-81-3 | Disulfidbindning | ≥99,0% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1,0% |
2 | FMOC-CYS (MMT) -OH | 177582-21-7 | Disulfidbindning | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
3 | Fmoc-cys (4-alllbutyrate) -OH | / | Disulfidbindning | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
4 | MPA (TRT) -OH | 27144-18-9 | Sekvensens slut | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
5 | FMOC-Thr (TBU) -OL | 189337-28-8 | Octreotid | ≥97,0% | ≤0,3% | ≤0,5% | ≤1,0% | ≤1,0% |
6 | FMOC-D-ARG (PBF) -OH | 187618-60-6 | Desmopressin | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤2,0% |
7 | FMOC-GLY-OH | 35665-38-4 | Bivalirudin | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
8 | FMOC-Gly-Gly-OH | 170941-79-4 | Terliperin | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
9 | FMOC-GLY-GLY-GLY-OH | / | Bivalirudin | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
10 | FMOC-Gly-Asp (TBU) -OH | / | Bivalirudin | ≥99,5% | / | ≤0,15% | ≤0,2% | ≤1,0% |
11 | BOC-CYS (TRT) -OH | 21947-98-8 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
12 | BOC-ARG (PBF) -OH | 200124-22-7 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
13 | Boc-ala-oh | 15761-38-3 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
14 | BOC-D-PHE-OH | 18942-49-9 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
15 | Boc-gly-oh | 4530-20-5 | Sekvensens slut | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
16 | BOC-Lys (BOC) -OH.DCHA | 15098-69-8 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
17 | BOC-Ser (TBU) -OH | 7738-22-9 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
18 | BOC-Thr (TBU) -OH | 13734-40-2 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
19 | Boc-d-ala-oh | 7764-95-6 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
20 | Boc-met-oh | 2488-15-5 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
21 | BOC-Tyr (TBU) -OH | 47375-34-8 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
22 | BOC-D-ARG (PDF) -OH | 187618-60-6 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
23 | BOC-ASP (OTBU) -OH.DCHA | 1913/12/8 | Sekvensens slut | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
24 | FMOC-HOMOARG (PBF) -OH | 1159680-21-3 | Eptifibatid | ≥98,5% | ≤0,2% | / | ≤0,5% | ≤2,0% |
25 | Fmoc-asp-oTBU | 129460-09-9 | Tymalfasin | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1,0% |
26 | FMOC-Tyr (ME) -OH | 77128-72-4 | Karbetocin | ≥98,5% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
27 | FMOC-EDR (BOC) -OH | 109425-55-0 | Atosiban Omnipressin Daptomycin | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤2,0% |
28 | FMOC-D-Tyr (ET) -OH | 162502-65-0 | Atosiban | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1,0% |
29 | Fmoc-asp (oall) -OH | 146982-24-3 | Melanotan | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
30 | Ac-nle-oh | 15891-49-3 | Melanotan | ≥99,0% | / | ≤0,3% | ≤0,3% | ≤1,0% |
31 | Fmoc-nle-oh | 77284-32-3 | Melanotan Afamelanotid | ≥99,0% | / | ≤0,3% | ≤0,3% | ≤1,0% |
32 | Ac-glu (otbu) -OH | 84192-88-1 | Argireline Acetyl octapeptide-3 | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
33 | AC-p-ala-oh · DCHA | / | Acetyltetrapeptid-5 | ≥99,0% | / | ≤0,3% | ≤0,3% | ≤1,0% |
34 | Fmoc-ß-ala-oh | 35737-10-1 | Acetyltetrapeptid-5 | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1,0% |
35 | FMOC-HYP (TBU) -OH | 122996-47-8 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
36 | Fmoc-thi-oh | 130309-35-2 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
37 | Fmoc-d-tic-oh | 130309-33-0 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
38 | Fmoc-oic-oh | 130309-37-4 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
39 | Boc-sar-oh | 13734-36-6 | Saralasin | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
40 | Fmoc-sar-oh | 77128-70-2 | Saralasin | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
41 | FMOC-Tyr (SO3NA) -OH.H2O | 106864-37-3 | Sinkalid | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
42 | FMOC-D-ASP (OTBU) -OH | 112883-39-3 | Daptomycin | ≥98,5% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
43 | Ac-sers (TBU) -OH | 77285-09-7 | Afamelanotid | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
44 | BOC-HOMOCYS (TRT) -OH | 201419-16-1 | Depreotid | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
45 | Fmoc-homocys (TRT) -OH | 167015-23-8 | Depreotid | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1,0% |
46 | Fmoc-dab-oh | 161420-87-7 | Ormgryn | ≥99,0% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1,0% |
*Max1 = max okänd renhet
Annan indikator:
- Ättiksyra: ≤0,02% (alla produkter)
- Etylacetat: ≤0,5% (alla produkter)
- Alkohol: ≤0,5% (alla produkter)
-Max UNKnove-orenhet: FMOC-TRP (BOC) -OH (143824-78-6) ≤0,3%; Andra ≤0,2%